PERCEPTIVE ADVISORS LLC 13D and 13G filings for enVVeno Medical Corporation:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-14 4:50 pm Purchase |
2024-09-30 | 13G | enVVeno Medical Corporation NVNO |
PERCEPTIVE ADVISORS LLC | 1,869,219 9.900% |
474,503 (+34.02%) |
Filing |
| 2024-02-23 4:16 pm Unchanged |
2024-02-23 | 13G | enVVeno Medical Corporation NVNO |
PERCEPTIVE ADVISORS LLC | 1,394,716 9.900% |
0 (Unchanged) |
Filing |
| 2024-02-14 4:38 pm Purchase |
2023-12-31 | 13G | enVVeno Medical Corporation NVNO |
PERCEPTIVE ADVISORS LLC | 1,394,716 9.900% |
457,201 (+48.77%) |
Filing |
| 2023-02-14 2:31 pm Sale |
2022-12-31 | 13G | enVVeno Medical Corporation NVNO |
PERCEPTIVE ADVISORS LLC | 937,515 9.900% |
-16,733 (-1.75%) |
Filing |
| 2022-02-14 4:38 pm Purchase |
2021-12-31 | 13G | enVVeno Medical Corporation NVNO |
PERCEPTIVE ADVISORS LLC | 954,248 9.900% |
954,248 (New Position) |
Filing |